Trial Details

UNKNOWN
Basic Information
Clinical ID c3459
Identifier NCT02027727
Trial Title Individualized Infiximab Dosing-Proof of Concept Study
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions OTHER: No Intervention
Participant Information
Sponsor Cedars-Sinai Medical Center
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2013-11
Primary Completion Date 2017-05
Completion Date 2018-03